ABN Amro Investment Solutions Purchases 1,280 Shares of Axon Enterprise, Inc $AXON

ABN Amro Investment Solutions boosted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 19.6% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,805 shares of the biotechnology company’s stock after buying an additional 1,280 shares during the period. ABN Amro Investment Solutions’ holdings in Axon Enterprise were worth $3,315,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of AXON. PNC Financial Services Group Inc. increased its stake in Axon Enterprise by 3.8% in the first quarter. PNC Financial Services Group Inc. now owns 12,817 shares of the biotechnology company’s stock valued at $5,443,000 after acquiring an additional 465 shares during the period. Commonwealth Financial Services LLC raised its position in Axon Enterprise by 21.8% in the first quarter. Commonwealth Financial Services LLC now owns 475 shares of the biotechnology company’s stock worth $202,000 after purchasing an additional 85 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Axon Enterprise by 1.3% during the first quarter. Dimensional Fund Advisors LP now owns 161,740 shares of the biotechnology company’s stock worth $68,681,000 after purchasing an additional 2,126 shares during the period. Parallel Advisors LLC lifted its stake in Axon Enterprise by 7.2% during the first quarter. Parallel Advisors LLC now owns 1,095 shares of the biotechnology company’s stock worth $465,000 after purchasing an additional 74 shares during the period. Finally, SEB Asset Management AB acquired a new stake in Axon Enterprise during the first quarter valued at approximately $6,729,000. Institutional investors own 79.08% of the company’s stock.

More Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon added two independent directors with deep technology and AI experience — former Dell executive Vivek Mohindra and AI entrepreneur Eiso Kant — which could strengthen oversight of the company’s AI-driven public safety platform and support its long-term strategy. Axon Enterprise (AXON) Appoints Two Directors With Deep Tech And AI Experience
• Positive Sentiment: Axon announced it will report second-quarter 2026 earnings on August 5, keeping the stock in focus as investors look for proof that revenue growth can continue and that management can improve profitability. Axon to Release Second Quarter 2026 Earnings on August 5, 2026
• Positive Sentiment: Investor interest has increased around Axon as a “trending stock,” suggesting more market attention ahead of earnings and key business updates. Axon Enterprise, Inc (AXON) Is a Trending Stock: Facts to Know Before Betting on It
• Neutral Sentiment: Analysts and commentary are highlighting a mixed setup: expected revenue growth remains strong, but earnings per share could soften, creating a valuation debate rather than a clear catalyst. Axon Enterprise (AXON) On Earnings Focus And AI Narrative Looks Undervalued
• Neutral Sentiment: Several articles focused on valuation, noting Axon may look expensive on cash flow but more reasonable on sales multiples, reinforcing uncertainty around whether the stock is fairly priced. Axon (AXON) Stock Could Be Fully Priced On Cash Flow Yet A Bargain On Sales
• Negative Sentiment: Margin concerns remain a headwind, with the company trying to offset rising costs through efficiency efforts while targeting stable margins in 2026 and better profitability by 2028. Can Axon Enterprise Improve Margin Performance Amid Rising Costs?

Insiders Place Their Bets

In other Axon Enterprise news, CRO Cameron Brooks sold 1,242 shares of the company’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $500.00, for a total transaction of $621,000.00. Following the transaction, the executive directly owned 49,710 shares in the company, valued at approximately $24,855,000. This represents a 2.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 2,000 shares of the company’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $400.00, for a total transaction of $800,000.00. Following the transaction, the insider owned 52,813 shares in the company, valued at approximately $21,125,200. The trade was a 3.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 58,989 shares of company stock valued at $30,527,983 over the last 90 days. Corporate insiders own 4.20% of the company’s stock.

Analyst Upgrades and Downgrades

AXON has been the topic of several analyst reports. JPMorgan Chase & Co. upped their price objective on Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. TD Cowen restated a “buy” rating on shares of Axon Enterprise in a research report on Wednesday. Weiss Ratings raised Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 8th. Morgan Stanley set a $600.00 price target on Axon Enterprise in a research note on Thursday, May 7th. Finally, Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $725.25.

Axon Enterprise Stock Performance

AXON stock opened at $491.90 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93. The company has a 50 day moving average price of $481.05 and a 200 day moving average price of $479.43. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $885.91. The stock has a market capitalization of $39.65 billion, a PE ratio of 197.55, a price-to-earnings-growth ratio of 10.03 and a beta of 1.38.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.01. The firm had revenue of $807.35 million for the quarter, compared to the consensus estimate of $778.90 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The business’s revenue for the quarter was up 33.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.47 EPS. Analysts forecast that Axon Enterprise, Inc will post 1.63 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.